# Progress and Market Development of Biotechnology in Saudi Arabia: A Survey: -

## TL;DR

This study explores the growth and challenges of Saudi Arabia's biotechnology sector under Vision 2030, focusing on perceptions of professionals in genetic research and industry.

## Contribution

The paper provides new insights into the perceptions of biotechnology professionals in Saudi Arabia regarding regulatory, economic, and collaborative challenges.

## Key findings

- 83.4% of respondents believe Saudi Arabia has potential as a regional biotech hub.
- 67.3% reported import barriers as a major challenge in the sector.
- Only 40% agreed that current regulations sufficiently support genetic testing growth.

## Abstract

Biotechnology is a transformative field with applications in healthcare,
agriculture, and industry. Saudi Arabia has prioritized biotechnology under
Vision 2030, aiming to
diversify its economy and establish itself as a regional biotech hub.
Initiatives like the Saudi
Genome Program and regulatory reforms by the SFDA highlight progress, yet
challenges such
as workforce shortages, import dependency, and ethical concerns persist.
This study examines
the perceptions of biotechnology professionals in Saudi Arabia regarding
sectoral progress, regulatory efficiency, and market opportunities, focusing
on genetic research, precision medicine,
and industrial biotechnology under Vision 2030.

A descriptive-analytical design was employed, targeting 150 biotechnology
researchers, industry professionals,
and policymakers via purposive sampling. Data were collected through a
validated Likert-scale
questionnaire assessing regulatory adequacy, collaboration, local
manufacturing, and import
challenges. Quantitative analysis was performed using SPSS v20.0.

While 40%
agreed that SFDA regulations support genetic testing growth, 35.3% reported
insufficient academia-industry-government collaboration. Optimism was high
for local manufacturing (76.7%)
and Saudi Arabia’s potential as a regional biotech hub (83.4%). However,
67.3% faced import
barriers, and 87.3% noted delays hindering research. Genetic data privacy
concerned 55.3%,
while 90.7% endorsed global partnerships for innovation.

Saudi Arabia’s biotechnology sector shows promise under Vision 2030, with
strong potential in local manufacturing
and regional leadership. However, regulatory harmonization, enhanced
collaboration, and infrastructure investment are critical to overcoming
import dependencies and workforce gaps.
Strategic policy interventions are recommended to sustain growth and
innovation.